Concord Biotech Limited has informed the Exchange regarding Appointment of Mr Raviraj Karia as Chief Financial Officer of the company w.e.f. December 18, 2025.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech Limited has appointed Mr. Raviraj Karia as the Chief Financial Officer (CFO) of the company, effective December 18, 2025. This is a key managerial personnel (KMP) appointment at the senior leadership level. The appointment has been communicated to the stock exchange as per listing compliance requirements. No details about his previous role or replacement of a prior CFO were mentioned in this filing.
A new CFO appointment signals a change in the company's financial leadership, which investors should monitor. It may indicate strategic shifts in financial planning, capital allocation, or reporting practices, though the long-term stock impact depends on the new CFO's track record and strategic priorities.